Ankle oedema and sympathetic activation

Drugs

Volumn 65, Issue SUPPL. 2, 2005, Pages 21-27

  Fogari, Roberto ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CAPTOPRIL; DIAZOXIDE; DIHYDROPYRIDINE DERIVATIVE; FELODIPINE; ISRADIPINE; LERCANIDIPINE; MANIDIPINE; NIFEDIPINE; NITRENDIPINE; VERAPAMIL; CALCIUM CHANNEL BLOCKING AGENT; NORADRENALIN;

ANKLE EDEMA; AUTOREGULATION; BLOOD FLOW; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; HUMAN; HYDROSTATIC PRESSURE; HYPERTENSION; REVIEW; SYMPATHETIC TONE; VASODILATATION; ADRENERGIC SYSTEM; ANKLE; ARTERIOLE; ARTHROPATHY; CHEMICALLY INDUCED DISORDER; CONTROLLED CLINICAL TRIAL; EDEMA; METABOLISM; RANDOMIZED CONTROLLED TRIAL;

ANKLE JOINT; ARTERIOLES; CALCIUM CHANNEL BLOCKERS; DIHYDROPYRIDINES; EDEMA; HUMANS; JOINT DISEASES; NOREPINEPHRINE; RANDOMIZED CONTROLLED TRIALS; SYMPATHETIC NERVOUS SYSTEM; VASODILATION;

EID: 26944472768     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200565002-00004     Document Type: Review

References (14)

1. Opie LH. Calcium channel antagonists. Part IV: Side effects and contraindications drug interactions and combinations. Cardiovasc Drugs Ther 1988; 2: 177-89
2. Messerli FH, Feng Z, Grandman AH. Combination therapy of calcium antagonists and ACE inhibitors - the incidence of vasodilatory oedema [Abstract]. Am J Hypertens 1999; 12: 119A
3. Papavassiliou MV, Vyssoulis GP, Karpanou EA, et al. Side effects of antihypertensive treatment with calcium channel antagonists [Abstract]. Am J Hypertens 2001; 14: 114A
4. Fogari R, Zoppi A, Lusardi P, et al. Efficacy and tolerability of manidipine hydrochloride in the long-term treatment of mild-moderate hypertension: Manidipine Efficacy in Long-Term Treatment Group. Blood Press 1996; 5 suppl. 5: 24-8
5. Gustafsson D, Lanne T, Bjerkhoel P, et al. Microvascular effects and oedema formation of felodipine in man. J Hypertens 1989; 7 suppl. 4: S161-7
6. Van Hamersvelt HW, Kloke JH, de Jong DJ, et al. Oedema formation with the vasodilators nifedipine and diazoxide: direct effect or sodium retention? J Hypertens 1996; 14: 1041-5
7. Lund-Johansen P, Stranden E, Helberg S, et al. Quantification of leg oedema in postmenopausal hypertensive patients treated with lercanidipine or amlodipine. J Hypertens 2003; 21: 1003-10
8. Pedrinelli R, Dell'Omo G, Nuti M, et al. Heterogeneous effect of calcium channel antagonists on leg oedema: a comparison of amlodipine versus lercanidipine in hypertensive patients. J Hypertens 2003; 21: 1969-73
9. Tikhonoff V, Mazza A, Casiglia E, et al. Differential effects of manidipine and lercanidipine on blood pressure, peripheral circulation and ankle oedema in hypertensive patients [Abstract]. J Hypertens 2004; 22 suppl. 2: 244
10. Fogari R, Malamani GD, Savino S, et al. Effects of different dihydropyridine calcium antagonists on pretibial subcutaneous tissue pressure in hypertensive patients [Abstract]. Am J Hypertens 1998; 11: 114A
11. Gustafsson D. Microvascular mechanisms involved in calcium antagonist oedema formation. J Cardiovasc Pharmacol 1987; 10 suppl. 1: S121-31
12. Messing M, Van Hessen H, Smith TL, et al. Microvascular actions of calcium channel antagonists. Eur J Pharmacol 1991; 198: 189-95
13. Fogari R, Zoppi A, Corradi L, et al. Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension. J Hypertens 2000; 18: 1871-5
14. Fogari R, Malamani GD, Zoppi A, et al. Manidipine has less oedematigeneous potential than amlodipine [Abstract]. J Hypertens 2000; 18 suppl. 2: S154-5